COMPOSITIONS OF BUPRENORPHINE AND u ANTAGONISTS
AssigneeAlkermes Pharma Ireland Limited
InventorsDaniel Deaver, Elliot Ehrich
Life of this patent
Estimating the term…
Abstract
The invention relates to a composition comprising buprenorphine and μ opioid receptor antagonist, wherein the composition is characterized by an Agonist Antagonist Activity Index (AAnAI) of between about 0.7 and about 2.2; wherein; AAnAI = [ C max ( BUP ) / EC 50 ] [ C max ( ANTAGONIST ) / IC 50 ] .
Claims4
A composition comprising 8 mg buprenorphine and 8 mg Compound-1, wherein Compound-1 has the structure:
A method of treating a depressive disorder comprising administering a composition comprising 8 mg buprenorphine and 8 mg Compound-1 to a patient in need thereof, wherein Compound-1 has the structure:
Dependencies are inferred from the claim text.